|
Volumn 14, Issue 4, 2008, Pages 315-321
|
Associated antimicrobial resistance in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes
|
Author keywords
Antimicrobial resistance; Associated resistance; Development; Empirical therapy; Resistance; Susceptibility
|
Indexed keywords
AMPICILLIN;
ANTIINFECTIVE AGENT;
CEFADROXIL;
CEFTAZIDIME;
CIPROFLOXACIN;
CLINDAMYCIN;
COTRIMOXAZOLE;
DOXYCYCLINE;
ERYTHROMYCIN;
FUSIDIC ACID;
GENTAMICIN;
IMIPENEM;
MECILLINAM;
METICILLIN;
NALIDIXIC ACID;
NITROFURANTOIN;
NORFLOXACIN;
PENICILLIN G;
PIPERACILLIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TRIMETHOPRIM;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ANTIBIOTIC THERAPY;
ARTICLE;
BACTERIUM ISOLATE;
CONTROLLED STUDY;
DRUG CHOICE;
DRUG TREATMENT FAILURE;
ESCHERICHIA COLI;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
SPECIES DIFFERENCE;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS PNEUMONIAE;
STREPTOCOCCUS PYOGENES;
ESCHERICHIA COLI;
PSEUDOMONAS AERUGINOSA;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS PNEUMONIAE;
STREPTOCOCCUS PYOGENES;
|
EID: 40549116344
PISSN: 1198743X
EISSN: 14690691
Source Type: Journal
DOI: 10.1111/j.1469-0691.2007.01946.x Document Type: Article |
Times cited : (31)
|
References (17)
|